Searched over 200M research papers
10 papers analyzed
These studies suggest that both hypo- and hyperglycemia are significant risks in various patient populations, and continuous glucose monitoring systems are effective tools for managing these conditions and reducing associated health risks.
20 papers analyzed
Hypoglycemia and hyperglycemia are two critical conditions related to abnormal blood glucose levels. Hypoglycemia refers to abnormally low blood glucose levels, while hyperglycemia indicates excessively high blood glucose levels. Both conditions can have significant health implications, particularly for individuals with diabetes and critically ill patients.
In critically ill patients, dysglycemia, which encompasses both hypo- and hyperglycemia, is frequently observed and can significantly affect clinical outcomes. Patients with acute kidney injury (AKI) are at an increased risk of experiencing both hypo- and hyperglycemia. Intensive insulin treatment (IIT) aimed at maintaining normal blood glucose levels (80-110 mg/dL) does not provide a protective effect on the kidneys and carries a high risk of hypoglycemia. Current guidelines recommend higher blood glucose targets (140-180 mg/dL) to mitigate this risk.
Continuous glucose monitoring (CGM) systems, such as the Guardian Continuous Monitoring System, have proven effective in alerting patients to hypo- and hyperglycemia in real-time. These systems help reduce the duration of hypoglycemic episodes and manage hyperglycemic excursions, although they may sometimes result in false alerts . CGM technology remains the best method for both reactive and predictive alarming of hypo- or hyperglycemia.
Even well-controlled elderly patients with type 2 diabetes can experience significant glycemic excursions. Continuous glucose monitoring has revealed that these patients often experience unrecognized hypoglycemic and hyperglycemic events, highlighting the importance of regular monitoring and appropriate management strategies.
In children with type 1 diabetes, both hypoglycemia and hyperglycemia experienced during brain development can predict patterns of subsequent cognitive performance. This underscores the need for careful glycemic control to prevent cognitive impairments.
The Endocrine Society's clinical practice guidelines emphasize the importance of reducing and preventing hypoglycemia in individuals with diabetes. Recommendations include the use of real-time CGM, structured diabetes education programs, and the use of glucagon preparations for managing severe hypoglycemia. These guidelines aim to improve clinical practice and healthcare system management for people living with diabetes.
In patients with heart failure following acute myocardial infarction, both hypo- and hyperglycemia are strong predictors of increased mortality. A U-shaped relationship exists between blood glucose levels and the incidence of all-cause death, with both low and high glucose levels associated with higher mortality rates.
Hypo- and hyperglycemia are critical conditions that require careful management, particularly in critically ill patients and individuals with diabetes. Continuous glucose monitoring and adherence to clinical guidelines can help mitigate the risks associated with these conditions. Understanding the implications of dysglycemia and implementing effective management strategies are essential for improving patient outcomes.
Most relevant research papers on this topic